title: Modulation of T-cell responses to alloantigens by TR6/DcR3.
abstract: TR6 (DcR3) is a new member of the TNF receptor (TNFR) family that lacks a transmembrane domain in its sequence, indicating that it is a secreted molecule. TR6 can bind to FasL and prevent FasL-induced apoptosis; it can also associate with LIGHT, another TNF family member. The role of TR6 in immune responses was investigated in this study. According to flow cytometry, recombinant human TR6-Fc binds to human LIGHT expressed on 293 cells or on activated human T cells and competes with the LIGHT receptor TR2 for the binding to LIGHT on these cells. Human TR6 could cross-react with mouse LIGHT in immunoprecipitation. TR6-Fc also downregulates cytotoxic T lymphocyte activity in vitro and graft-versus-host responses in mice. Moreover, TR6-Fc modulates lymphokine production by alloantigen-stimulated mouse T cells. TR6-Fc ameliorated rejection response to mouse heart allograft. These results indicate that TR6 can dampen T-cell responses to alloantigens. Such regulatory effects of TR6 probably occur via interference with interaction between pairs of related TNF and TNFR family members, LIGHT/TR2 being one of the possible candidate pairs.
authors.affiliation: Human Genome Sciences Inc., Rockville, Maryland, USA. jun_zhang@hgsi.com
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.forename: T W
authors.initials: TW
authors.lastname: Salcedo
authors.forename: X
authors.initials: X
authors.lastname: Wan
authors.forename: S
authors.initials: S
authors.lastname: Ullrich
authors.forename: B
authors.initials: B
authors.lastname: Hu
authors.forename: T
authors.initials: T
authors.lastname: Gregorio
authors.forename: P
authors.initials: P
authors.lastname: Feng
authors.forename: S
authors.initials: S
authors.lastname: Qi
authors.forename: H
authors.initials: H
authors.lastname: Chen
authors.forename: Y H
authors.initials: YH
authors.lastname: Cho
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.forename: P A
authors.initials: PA
authors.lastname: Moore
authors.forename: J
authors.initials: J
authors.lastname: Wu
mesh_terms: D000818:Animals; D002460:Cell Line; D005260:Female; D005434:Flow Cytometry; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000378:metabolism; D016027:Heart Transplantation / Q000502:physiology; D006801:Humans; D015151:Immunoblotting; D016898:Interferon-alpha / Q000378:metabolism; D016753:Interleukin-10 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D007519:Isoantigens / Q000276:immunology* / Q000378:metabolism; D008562:Membrane Glycoproteins; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011233:Precipitin Tests; D011956:Receptors, Cell Surface / Q000276:immunology* / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology / Q000378:metabolism*; D053323:Receptors, Tumor Necrosis Factor, Member 6b; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D013154:Spleen / Q000166:cytology / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology* / Q000502:physiology; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016898:Interferon-alpha; D015850:Interleukin-6; D007519:Isoantigens; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; D011956:Receptors, Cell Surface; D018124:Receptors, Tumor Necrosis Factor; D053323:Receptors, Tumor Necrosis Factor, Member 6b; D011993:Recombinant Fusion Proteins; C505911:TNFRSF6B protein, human; C505914:TNFSF14 protein, human; C505915:Tnfsf14 protein, mouse; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10; D016178:Granulocyte-Macrophage Colony-Stimulating Factor